AMUNDI STOXX EUROPE 600 ESG UCITS ETF DR (EPA: C6E)
129.01
+0.13 (0.10%)
Aug 30, 2024, 5:35 PM CET
17.89% (1Y)
Assets | 796.25M |
Expense Ratio | 0.18% |
PE Ratio | n/a |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | -95.42% |
Volume | 4,205 |
Open | 128.03 |
Previous Close | 128.88 |
Day's Range | 128.03 - 129.43 |
52-Week Low | 102.10 |
52-Week High | 129.43 |
Beta | 1.03 |
Holdings | 480 |
Inception Date | Apr 18, 2018 |
About C6E
AMUNDI STOXX EUROPE 600 ESG UCITS ETF DR is an exchange traded fund launched and managed by Amundi Asset Management. The fund invests in the public equity markets of Europe. It uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of companies across all market capitalizations. It seeks to replicate the performance of the STOXX Europe 600 Index, by employing synthetic replication methodology. AMUNDI STOXX EUROPE 600 ESG UCITS ETF DR was formed on August 20, 2009 and is domiciled in Luxembourg.
Asset Class Equity
Category Total Market
Stock Exchange Euronext Paris
Ticker Symbol C6E
Provider Amundi
Index Tracked STOXX Europe 600 ESG+ - EUR - Benchmark TR Net
Performance
C6E had a total return of -95.42% in the past year. Since the fund's inception, the average annual return has been -12.89%, including dividends.
Top 10 Holdings
24.30% of assetsName | Symbol | Weight |
---|---|---|
Novo Nordisk A/S | NOVO.B | 4.10% |
ASML Holding N.V. | ASML | 3.38% |
NESTLE SA-REG | NESN.SW | 2.67% |
AstraZeneca PLC | AZN | 2.57% |
NOVARTIS AG-REG | NOVN.SW | 2.33% |
ROCHE HOLDING AG - GENUSSS | ROG.SW | 2.24% |
SAP SE | SAP | 2.11% |
LVMH Moët Hennessy - Louis Vuitton, Société Européenne | MC | 1.81% |
HSBC Holdings plc | HSBA | 1.56% |
Unilever PLC | ULVR | 1.54% |